CellX
Palo Alto
About CellX
CellX is creating the world's first mushroom protein from morel mycelium fermentation. Our ingredient and product solutions can be applied to savory snacks, protein powders, and meat alternatives. We are also licensing existing IPs to help accelerate the commercialization of cultivated meat. Our technology offerings include suspension cell lines and serum-free media that have achieved 30M/ml cell density and <$5/L media cost, tested at the 2,000L scale.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $26.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2023)
- Website: cellx.co
- Phone: [email protected]
Industries & Categories
Agriculture, Alternative Protein, Biotechnology, Food and Beverage
Social Profiles
Canonical: https://fsome.com/organization/cellx-109064 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.